45 Biggest Movers From Yesterday

Gainers

• ATA Creativity Global AACG gained 114.3% to close at $2.55.
• Hoth Therapeutics, Inc. HOTH surged 85.7% to settle at $1.30 after the company announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ.
• NexTier Oilfield Solutions Inc. NEX climbed 26.6% to settle at $4.90 on Tuesday after the company issued an operational update and guidance for the fourth quarter. The company said it expects Q4 revenue of $500-$510 million, reflecting a surge of more than 25% from Q3 2021.
• NLS Pharmaceutics AG NLSP rose 26.1% to close at $1.50 after the company announced the USPTO granted the company U.S. Patent No. 11207271, entitled A Mazindol Ir/Sr Multilayer Tablet And Its Use For The Treatment Of Attention Deficit/Hyperactivity Disorder.
• Reliance Global Group, Inc. RELI jumped 23% to settle at $9.32.
• REE Automotive Ltd. REE gained 20.6% to close at $6.73.
• Winc, Inc. WBEV gained 20% to close at $6.97.
• Oragenics, Inc. OGEN climbed 18.4% to close at $0.56. The company reported in Form 4 filing that Director Robert Koski bought 1 million shares at an average price of $0.47 per share.
• ReTo Eco-Solutions, Inc. RETO gained 18.4% to settle at $1.74 after the company announced it entered into an Equity Acquisition Agreement with Hainan REIT Mingde Investment Holding Co.
• Arcadia Biosciences, Inc. RKDA rose 17.8% to close at $1.39 on continued momentum after the company was granted a notice of allowance for a US patent titled 'Wheat Having Resistance to Glyphosate Due to Alterations in 5-Enol-Pyruvylshikimate-3 Phosphate Synthase.'
• NeuroBo Pharmaceuticals, Inc. NRBO jumped 16.7% to close at $1.54 after gaining around 10% on Monday.
• Plus Therapeutics, Inc. PSTV surged 16.4% to close at $1.28 after the company announced it has met two significant milestones as it progresses toward cGMP manufacture of Rhenium-186 NanoLiposome.
• eMagin Corporation EMAN gained 15.5% to settle at $1.64.
• Agrify Corporation AGFY rose 15.3% to close at $11.14. Agrify announced Tuesday that it has inked a definitive agreement for its largest Agrify Total Turn-Key Solution partnership to date with Gold Leaf Florida LLC.
• American Realty Investors, Inc. ARL surged 14.7% to close at $13.75.
• New York City REIT, Inc. NYC gained 13.8% to settle at $12.29.
• Immix Biopharma, Inc. IMMX shares rose 12.3% to close at $6.49 on continued momentum after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the treatment of rhabdomyosarcoma, a life-threatening form of pediatric cancer in children.
• Ford Motor Company F climbed 11.7% to close at $24.31 after the company announced it plans to nearly double production of the F-150 Lightning all-electric truck.
• TherapeuticsMD, Inc. TXMD gained 11.2% to close at $0.4376 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.
• TD Holdings, Inc. GLG rose 11.1% to close at $0.4795.
• Heritage Insurance Holdings, Inc. HRTG gained 10.9% to close at $6.53 after the company announced a $25 million buyback.
• Reata Pharmaceuticals, Inc. RETA gained 9% to close at $29.79.
• Aravive, Inc. ARAV gained 7.4% to close at $2.63.
• iSpecimen Inc. ISPC shares gained 5.5% to close at $8.50 after Craig-Hallum initiated coverage on the stock with a Buy rating and $20 price target.

Check out these big penny stock gainers and losers

Losers

• Gritstone bio, Inc. GRTS dipped 42.4% to close at $7.02 as the company shared data from the first cohort (10 µg dose) of the Phase 1 booster trial of self-amplifying mRNA (samRNA) COVID-19 vaccine.
• Zhangmen Education Inc. ZME shares fell 38.1% to close at $2.80 on Tuesday.
• AVROBIO, Inc. AVRO shares declined 36.6% to settle at $2.56 after the company reported it is shifting its portfolio priorities to focus on other clinical-stage programs and extending its cash runway into the first quarter of 2024. It is deprioritizing its Fabry disease program.
• Heliogen, Inc. HLGN fell 24.1% to settle at $10.30 after declining around 13% on Monday.
• Valneva SE VALN fell 22.6% to close at $39.47. Valneva, last month, said its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.
• iCAD, Inc. ICAD fell 21.4% to close at $5.88 after the company issued Q4 and FY21 sales guidance below estimates.
• Jowell Global Ltd. JWEL fell 21.2% to close at $6.93 after dipping around 60% on Monday.
• Genprex, Inc. GNPX fell 20.3% to close at $2.79. Genprex expanded gene therapy oncology pipeline to include small cell lung cancer.
• uCloudlink Group Inc. UCL dipped 18.4% to settle at $3.10.
• BlueCity Holdings Limited BLCT dropped 16.1% to close at $1.51. BlueCity recently announced it received an acquisition offer for the company at $3.70/share.
• Nuverra Environmental Solutions, Inc. NES declined 15.2% to settle at $2.57.
• Everspin Technologies, Inc. MRAM shares fell 14.9% to close at $10.86.
• ShiftPixy, Inc. PIXY fell 14.4% to settle at $1.01.
• Intra-Cellular Therapies, Inc. ITCI shares dropped 14.1% to settle at $44.68 after the company reported a $400 million common stock offering.
• Trio-Tech International TRT shares fell 14% to close at $10.70.
• Armstrong Flooring, Inc. AFI fell 13.7% to close at $2.39. Armstrong Flooring shares climbed around 40% on Monday after the company said it is exploring a sale of the business.
• Equillium, Inc. EQ dropped 13.3% to settle at $3.60. Equillium’s Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective.
• Global-e Online Ltd. GLBE shares fell 13.2% to close at $55.01.
• Dada Nexus Limited DADA fell 13.1% to close at $11.45. Shares of Chinese companies traded lower in reaction to new Chinese cybersecurity rules from February 15.
• Pear Therapeutics, Inc. PEAR shares fell 12.2% to close at $6.70. BTIG, on Monday, initiated coverage on the stock with a Buy rating and announced a $12 price target.
• Abcam plc ABCM shares dipped 9% to close at $21.75. Alamar Biosciences and Abcam reported a strategic partnership to further understanding of the human proteome.